Why did we contact them?
We spoke with Prof. Martin Jinek, Professor at the Department of Biochemistry at the University of Zurich and head of the Jinek Laboratory. He has many years of experience working with CRISPR-Cas systems and was part of the original research team, alongside Emmanuelle Charpentier and Jennifer Doudna, that first described how CRISPR-Cas9 can be used for genome editing. We asked him which Cas protein would be most suitable for our project and whether we should purify the protein ourselves or order it commercially.